Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Abstract The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV). The patients with treatment-naïve mCNV received 1 + PRN intravitreal bevacizumab from March 2008 to F...
Main Authors: | Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, Yun-Ju Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-09-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-018-32761-z |
Similar Items
-
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
by: Shih-Lin Chen, et al.
Published: (2021-09-01) -
Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks
by: Ebru Esen, et al.
Published: (2015-01-01) -
Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01) -
Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01) -
Choroidal structural changes determined by the binarization method after intravitreal aflibercept treatment in neovascular age-related macular degeneration
by: Emine Temel, et al.
Published: (2021-08-01)